Prenatal Choline Supplementation Boosts Child Brain Development and IQ Scores
A major clinical trial at the University of Colorado Anschutz Medical Campus shows that prenatal choline supplementation improves cognitive performance and social behavior in children, raising IQ scores by eight points at age four.
A new clinical trial conducted at the University of Colorado Anschutz Medical Campus reveals that prenatal supplementation with phosphatidylcholine, a form of choline, significantly supports fetal brain development, improves cognitive performance, and enhances social behavior in children.
The randomized clinical trial, published in the American Journal of Obstetrics and Gynecology, evaluated children whose mothers took phosphatidylcholine during pregnancy compared to a control group receiving a placebo. According to the findings, children in the supplement group exhibited fewer social withdrawal issues and scored higher on standardized cognitive tests by age four.
Dr. Robert Freedman, professor of psychiatry at the Anschutz Medical Campus and senior author of the study, noted that this represents the largest randomized clinical trial of prenatal choline supplementation to date. Researchers observed an average increase of approximately eight points in general intelligence quotient scores among four-year-old children in the treatment group.
Methodology and Findings
The study enrolled 206 pregnant women, randomly assigning them at the 16th week of gestation to receive either 9,000 milligrams of phosphatidylcholine daily or a placebo until delivery. Researchers tracked the children's development from 18 months to four years of age, assessing cognitive performance and behavioral patterns.
Among children who completed behavioral evaluations, only 4% in the supplement group experienced increased social withdrawal issues, compared to 24% in the placebo group. Furthermore, children in the treatment group demonstrated better language development and reduced indicators associated with autism spectrum disorders, although the supplement did not significantly alter attention-related difficulties.
Mechanism and Recommendations
Choline operates by activating a receptor produced by the CHRNA 7 gene in developing nerve cells, facilitating essential neural connections before birth. Researchers emphasize that obtaining sufficient choline levels through standard diet alone is exceptionally difficult, making supplementation necessary during pregnancy.
While the trial reported no significant safety concerns, authors advise careful interpretation of the results, noting that approximately one-third of participants did not complete the four-year follow-up assessments, relying instead on parental reports.
